Potential rocket 🚀 (veterinary)

PetIQ, Inc. is a holding company that manufactures and distributes products and provides services for the health of pets. The company was founded in 2010 and is headquartered in Eagle, Idaho. The PetIQ network includes 3,400 inpatient clinics and 70,000 mobile, 100+ wellness centers, 1.2 million pets served in 2019 The company's products include 6 main brands and 4 additional ones. The company sells prescription drugs for pets, including products for arthritis, thyroid, diabetes, and pain, as well as heartworm prevention, antibiotics, and over-the-counter drugs and supplies such as flea and tick products in various forms, chewing gums and collars. The name of the drugs produced by the company has 1200 names. The products are sold through 250 veterinary networks. Capitalization $ 700 million

The company is on the verge of breakeven in 2021. In 2021, analysts predict the campaign will close with a profit for the first time in 4 years. The negative financial result was associated with high caps. costs associated with the expansion of the network of clinics.

The $ PETQ quote is trading near the annual low. After bouncing from the upper border of the ascending channel in May this year, the price is approaching the $ 21-23 support block. Where do I expect a trend reversal. The first target is the lower border of the ascending channel at $ 29. The second (will have to wait) - closing the gap at $ 34.5.

NOT IRR.